Biodelivery Sciences International reported $9.06M in Net Income for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acelrx Pharmaceuticals ACRX:US $ -8.38M 1.48M
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
Agile Therapeutics AGRX:US $ -16.77M 0.86M
Biocryst Pharmaceuticals BCRX:US $ -58.8M 15.6M
Cti Biopharma CTIC:US $ -24.18M 4.5M
Daiichi Sankyo 4568:JP Y 27246M 7974M
Depomed DEPO:US $ 3.74M 17.91M
Endo International Ordinary Shares ENDP:US $ -77.21M 61.71M
JAZZ PHA JAZZ:US $ -52.83M 310.48M
Johnson & Johnson JNJ:US $ 3667M 2611M
Knight Therapeutics Inc GUD:CN C$ -8586000 37.59M
Lannett LCI:US $ -22.34M 155.54M
Mannkind MNKD:US $ -4.43M 31.1M
Nektar Therapeutics NKTR:US $ -129.71M 4.19M
Pacira Pharmaceuticals PCRX:US $ 17.66M 1.42M
Pfizer PFE:US $ 8146M 2582M
Redhill Biopharma RDHL:US $ -21.39M 7.73M
Revance Therapeutics RVNC:US $ -74.38M 2.18M
Teva Pharmaceutical TEVA:IT 290M 83M